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Tubulointerstitial nephritis and uveitis (TINU) syndrome is a rare disease, often underdiagnosed or 
misdiagnosed in children. We describe the case of a 12-year-old boy who presented to Severance 
Hospital with a 1-month history of bilateral conjunctival injection. He was first evaluated by an 
Ophthalmologist in another hospital and diagnosed with panuveitis. Laboratory tests indicated renal 
failure, and a renal biopsy confirmed the diagnosis of acute tubulointerstitial nephritis. An extensive 
exclusion of all possible causes allowed a diagnosis of TINU syndrome. The patient was treated with 
a systemic corticosteroid (initially prednisolone, 2 mg/kg and later deflazacort 1 mg/kg) and topical 
steroid drops for 1 month. Azathioprine was later added to the treatment regimen and the systemic 
steroid was slowly tapered. The final outcome of renal-ocular disease was favorable in the patient. 
However, long-term follow-up is necessary to properly manage frequent relapses and incomplete renal 
recovery. TINU should be considered as a differential diagnosis in children with uveitis or acute renal 
failure. 
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Introduction
Tubulointerstitial nephritis and uveitis (TINU) syndrome is a rare disease that affects the 
renal tubular cells and uvea, causing tubulointerstitial nephritis and bilateral or unilateral 
uveitis. First described in 1975 by Dobrin et al.1), TINU usually occurs in adolescents and 
young women. Till date, approximately 200 cases have been reported worldwide; 5 cases 
have been reported in Korean literature, of which 2 were pediatric patients2-6). We report 
the third case of TINU syndrome in pediatric patients and that was firstly treated with 
azathioprine in Korea. 
Case report
A 12-year-old boy presented to Severance Hospital with a 1-month history of bilateral 
injected conjunctiva. He was initially evaluated by an Opthalmologist in another hospital 
and diagnosed with uveitis. Laboratory tests showed elevated blood urea nitrogen and 
creatinine levels; 36.0 and 3.07 mg/dL, respectively. He was therefore transferred to our 
hospital for further evaluation and management. He did not have generalized edema or 
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costovertebral angle tenderness. His temperature was 36.9°C, 
and his blood pressure was 123/67 mmHg. He had anemia, 
hemoglobin was 9.7 g/dL (range, 14–18 g/dL). Serum sodium and 
potassium was 140/3.4 mmol/L and albumin was 4.2 g/dL (range, 
3.8–5.4 g/dL). Estimated glomerular filtration rate was 30.9 mL/
min/1.73 m2. Spot urinary protein to creatinine ratio was elevated 
to 1.27. Low-molecular-weight proteinuria, including urinary β2 
micro globulin level was increased to 6.68 mg/L (range, 0.0–0.25 
mg/L), suggesting low-molecular-weight proteinuria due to 
proximal tubule injury.
IgG and IgE were slightly elevated to 1,547 mg/dL (range, 639–
1,349 mg/dL) and 232 mg/dL (range 0–230 mg/dL). On admis-
sion, CD3 and CD20 were 50.7% (range, 56%–84%) and 31.7% 
(range, 0%–20%), respectively. CD20 was decreased to 7.8% after 
3 months. Immunologic tests, including antinuclear antibody, 
anti-ds DNA antibody, rheumatoid factor, and antineutrophil 
cytoplasmic antibody, were all negative. Human leukocyte anti-
gen (HLA) B27 and HLA B51 genotyping were also negative.
Abdominal ultrasonography was unremarkable except for mild 
pelvic ascites. A dimercaptosuccinic acid renal scan demonstrated 
mildly decreased uptake in the upper pole of the left kidney 
with renal function of 62.59% and 37.41% in the right and left 
kidney, respectively. Renal biopsy findings showed interstitial 
inflammation and tubular atrophy (Fig. 1).
The patient was treated with a systemic oral glucocorticoid 
(prednisolone, 2 mg/kg daily). The acute renal failure and uvei-
tis (Fig. 2) gradually improved. After 4 weeks of treatment, ab-
dominal striae appeared as a side effect of prednisolone, and 
therefore, treatment was changed from prednisolone to deflaza-
cort, which has fewer side effects. After 8 weeks of systemic 
steroid treatment, the deflazacort was slowly tapered. An immu-
nosuppressant, azathioprine, was added at week 16 and main-
tained 1.7 mg/kg daily. We reduced the dose of azathiprine to 0.86 
mg/kg daily at the 68th week of treatment, and the creatinine 
level had decreased to 0.93 mg/dL at last follow-up (Fig. 3). Spot 
urinary protein to creatinine ratio was also maintained for values 
less than 1.0. The patient’s uveitis was treated with topical steroid 
and antibiotic drops. The final outcomes of both the renal and 
ocular manifestations of the disease were favorable.
Discussion
Although the pathogenesis of TINU syndrome remains elusive, 
TINU syndrome is thought to be an immune disorder and asso-
ciated with HLA genotype7). This is supported by the high levels of 
immune activation markers such as soluble tumor-necrosis factor 
receptors, soluble interleukin-2 receptors, and neopterine found 
in patients with TINU7). Additionally, the ratio of CD4+ to CD8+ 
peripheral blood lymphocytes is reduced, and, on renal biopsy, the 
majority of cells infiltrating the interstitium are T-lymphocytes 
on renal biopsy7). Infectious agents such as Epstein-Barr virus 
and Chlamydia trachomatis, have been linked to some cases of 
Fig. 1. Renal biopsy specimen showing mononuclear cell infiltration of 
the interstitium and tubular atrophy and necrosis (H&E, ×100).
Fig. 2. Fundoscopy of the right eye (A) and the left eye (B). Both fundoscopy images showing inflam-
mation of retina (arrows).
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TINU8,9); drugs such as nonsteroidal anti-inflam matory agents 
and antibiotics are regarded as important triggers in other cases10). 
However, our patient did not have any of these triggers. 
Some studies suggest that modified C-reactive protein (mCRP) 
may be involved in the pathogenesis of TINU. The mCRP results 
from dissociation of CRP under conditions such as altered pH, 
high urea concentration, or low calcium concentration11). Tan et 
al.11) reported that anti-mCRP autoantibodies were detected in all 
TINU patients, renal biopsies revealed upregulated expression of 
mCRP, and IgG was colocalized with mCRP in human renal and 
uveal tissues.
Patients with TINU syndrome usually present with vague symp-
toms such as anorexia, fever, weight loss, fatigue, and polyuria, 
with or without uveitis12). Multisystem involvement, including 
hyperthyroidism and diabetes mellitus, may occur13); however, 
in most patients diagnosed with acute tubulointerstitial nephritis 
(ATN), endocrine and ophthalmic examination is not performed. 
Many cases show that TINU did not have typical symptoms, and 
the timing of uveitis was variable. Therefore, all patients with 
ATN should undergo a slit-lamp examination for uveitis.
Patients with TINU syndrome have been treated successfully 
with corticosteroids14), but the use of systemic steroids may be 
restricted in patients with significant tubulointerstitial injury. 
However, uveitis must be treated because of its poor prognosis. 
Some patients require additional immunosuppressive drugs 
such as azathioprine, methotrexate, or cyclosporine if steroid 
resistance, recurrence of uveitis, or significant steroidal side-
effects occur15). In our case, the patient developed Cushingoid fea-
ture, abdominal striae. To our knowledge, this is the first case that 
was treated with azathiprione in pediatric patients with TINU in 
Korea.
To date, 2 cases of pediatric TINU syndrome have been reported 
in the Korean literature. The first case was a 14-year old girl 
and her nephritis resolved spontaneously, but her uveitis, which 
was treated with topical steroids, had a remitting and relapsing 
course2). The second case was a 9-year-old boy with severe im-
munologic dysregulation, especially T cell5). He was treated with 
systemic steroid, oral prednisolone (2 mg/kg), but his uveitis was 
not responsive to high dose systemic prednisolone but responded 
to cyclosporine A5). In second case, Lee et al.5) sug gested that T 
cells had most important role in pathogenesis of TINU syndrome. 
However, our patient showed CD20 elevation and normal 
CD3 level which means B cells activation. And he responded 
to azathioprine, which inhibit T cells and B cells proliferation. 
To our knowledge, ours is the first patient in Korea treated 
with azathioprine for pediatric TINU syndrome and he was 
successfully treated. The outcome of renal involvement of TINU is 
excellent in most cases; however, up to 48.6% patients experience 
symptomatic ocular complications14).
TINU syndrome is very rare, but it is important to consider 
it in young patients with vague symptoms. Early recognition 
is vital for a better prognosis. Therefore, this diagnosis should 
be considered when evaluating patients with tubulointerstitial 
nephritis or uveitis. Further studies are necessary to determine 
accurate pathophysiology and universal recommendation of 
treatment for TINU syndrome.
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Fig. 3. Renal function and medication over time. TINU, tubulointerstitial nephritis and uveitis.
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